This is a video synopsis/summary of a panel discussion involving Marla Dubinsky, MD; David Rubin, MD; Miguel Regueiro, MD; Remo Panaccione, MD, FRCPC; and Sara Horst, MD, MPH.

The conversation focuses on addressing new patients who have previously struggled with ineffective therapies for Crohn's disease. The challenge lies in instilling faith and confidence in these patients that there are better options available and that the new therapeutic approaches will lead them toward improved health.

The speakers emphasize a team approach, assuring the patients that they won't face the challenges alone. He highlights the importance of having a clear plan and the ability to pivot to alternative strategies if needed. The notion of a continuous plan and not viewing the current therapy as the end of the line is crucial in giving patients hope.

The speakers also discuss the concept of disease modification, citing studies that show better outcomes for patients in deep endoscopic remission. However, they acknowledge the complexity of conveying this concept to patients, especially when they might be feeling well at the moment.

One of the experts breaks down the treatment approach into small time increments, urging patients to focus on the next 2 months and assuring them that adjustments can be made as needed. This approach aims to counter the sense of hopelessness that some patients may feel, particularly those who have undergone repeated steroid treatments with associated consequences.

In summary, the conversation underscores the importance of providing hope, emphasizing a team approach, and ensuring patients understand that ongoing adjustments and new therapeutic options are available to address their unique situations.

Video synopsis is AI-generated and reviewed by HCPLive editorial staff.